NR3C1 and Cushing syndrome: We suggest that NR3C1 sequencing be completed in patients with persistent biochemical hypercortisolism in the absence of clinical signs/symptoms of Cushing syndrome and in patients with a known or suspected family history of glucocorticoid resistance.